Cambrian BioPharma Inc, Ten Percent Owner at Faeth Therapeutics, holds 130.14K shares in Faeth Therapeutics (Ticker: FTH). Most recently, Cambrian BioPharma Inc Sold 25,000 shares of Faeth Therapeutics on Jun 01, 2026 for an estimated value of $500.54K.
What is the percentage of profitable transactions made by Cambrian BioPharma Inc?
The percentage of profitable transactions made by Cambrian BioPharma Inc is 0%.
What is the average return per transaction made by Cambrian BioPharma Inc?
The average return per transaction made by Cambrian BioPharma Inc is -80.20%.
What stocks does Cambrian BioPharma Inc hold?
Cambrian BioPharma Inc holds: FTH stocks.
What was Cambrian BioPharma Inc’s latest transaction?
Cambrian BioPharma Inc latest transaction was an Informative Sell of $500.54K.
What was Cambrian BioPharma Inc's most profitable transaction?
Cambrian BioPharma Inc’s most profitable transaction was an Informative Sell of FTH stock on June 1, 2026. The return on the trade was -41.40%.
What is Cambrian BioPharma Inc's role in Faeth Therapeutics?
Cambrian BioPharma Inc's role in Faeth Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.